GlassScriptPhysician profile
Kevin T Coolbaugh
NPI 1306842695
$2,728.06
in general payments reported to CMS, 2019-2025
22 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $92.70 · 2021: $299 · 2022: $349 · 2023: $198 · 2024: $357 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.57 |
| Education | $108.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $520.01 | 2020-2025 | Lensx, Total30, Tryptyr |
| Bausch & Lomb Americas INC. | $425.27 | 2022-2025 | Miebo, Infuse, Vyzulta |
| Mallinckrodt Hospital Products INC. | $346.86 | 2024-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $244.60 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $238.65 | 2024-2025 | Xdemvy |
| Allergan, INC. | $137.00 | 2019-2022 | |
| Genentech USA, INC. | $134.73 | 2022-2025 | Vabysmo |
| Harrow Eye, LLC | $122.20 | 2024 | Vevye |
| Biotissue Holdings INC. | $90.62 | 2020-2022 | |
| Rxsight INC | $80.10 | 2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Aerie Pharmaceuticals, INC. | $62.36 | 2019 | |
| Dompe US, INC. | $51.98 | 2024-2025 | Oxervate |
| Abbvie INC. | $40.52 | 2022-2023 | Durysta |
| Shire North American Group INC | $37.58 | 2019 | |
| Amgen INC. | $32.72 | 2024-2025 | Tepezza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $29.48 | 2025 | Clariti Contact Lens, Myday Contact Lens |
| Novartis Pharmaceuticals Corporation | $29.45 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $27.08 | 2024 | Rayone Emv, Rayone Aspheric, Omidria |
| Thea Pharma INC. | $22.27 | 2025 | Iyuzeh |
| Astellas Pharma US INC | $21.72 | 2025 | Izervay |
| Omeros Corporation | $16.60 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $16.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Coolbaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.